Patient with Colorectal Metachronous Liver Metastases Associated with Extrahepatic Disease: Surgical Strategies

$0.00

José Manuel Ramia Ángel, Roberto de la Plaza Llamas and José Edecio Quiñones Sampedro
Guadalajara University Hospital, Guadalajara, Spain

Series: Cancer Etiology, Diagnosis and Treatments
BISAC: MED062000

Colorectal cancer (CRC) is the third most frequent neoplasm in the world, with an approximate incidence of 54 cases per 100,000 inhabitants in men and 34 per 100,000 in women. CRC is the second most frequent cause of death due to cancer in developed countries. Half of these patients develop hepatic metastasis in the course of the disease, 25% of them synchronously. The five-year survival of patients with CRC stage IV not treated surgically is 0-7%. Hepatic resection is considered to be the treatment of choice for colorectal liver metastases (CLM). (Imprint: Nova)

Clear

Details

Table of Contents

Preface

Introduction

Summary of Published Series of Patients with CLM and EHD

Extrahepatic Disease, By Organs

Conclusion

References

Index

Additional information

Binding